Hannah L Kalvin

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Circulating Tumor

Replacement Therapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Pigment cell & melanoma research

This page only lists publications with an associated author ORCID identifier.

Publications

James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Kimberly Loo, Hannah L Kalvin, Katherine S Panageas, Margaret K Callahan, Paul B Chapman, Parisa Momtaz, Alexander N Shoushtari, Jedd D Wolchok, Michael A Postow, Allison Betof Warner
Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1. Pigment cell & melanoma research (2023)